Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Scalable mesenchymal stem cell enrichment from bone marrow aspirate using deterministic lateral displacement (DLD) microfluidic sorting

Scalable mesenchymal stem cell enrichment from bone marrow aspirate using deterministic lateral displacement (DLD) microfluidic sorting

Thumbnail Image
Download
Name

D3LC00379E.pdf

Size

1.69 MB

Format

Adobe PDF

Checksum (MD5)

237e91d5a4c669f8f923b9c246dd73f9

Author(s)
Tan Kwan Zen, Nicholas
•
Zeming, Kerwin Kwek
•
Teo, Kim Leng
•
Loberas, Mavis
•
Lee, Jialing
•
Goh, Chin Ren
•
Yang, Da Hou
•
Oh, Steve
•
Hui Hoi Po, James
•
Cool, Simon M.
more
Date Issued
2023
Journal
Lab on a Chip
Publisher
Royal Society of Chemistry
Citation
Tan Kwan Zen, Nicholas, Zeming, Kerwin Kwek, Teo, Kim Leng, Loberas, Mavis, Lee, Jialing et al. 2023. "Scalable mesenchymal stem cell enrichment from bone marrow aspirate using deterministic lateral displacement (DLD) microfluidic sorting." Lab on a Chip, 23 (19).
Version
Final published version
Abstract
The growing interest in regenerative medicine has opened new avenues for novel cell therapies using stem cells. Bone marrow aspirate (BMA) is an important source of stromal mesenchymal stem cells (MSCs). Conventional MSC harvesting from BMA relies on archaic centrifugation methods, often leading to poor yield due to osmotic stress, high centrifugation force, convoluted workflow, and long experimental time (∼2–3 hours). To address these issues, we have developed a scalable microfluidic technology based on deterministic lateral displacement (DLD) for MSC isolation. This passive, label-free cell sorting method capitalizes on the morphological differences between MSCs and blood cells (platelets and RBCs) for effective separation using an inverted L-shaped pillar array. To improve throughput, we developed a novel multi-chip DLD system that can process 2.5 mL of raw BMA in 20 ± 5 minutes, achieving a 2-fold increase in MSC recovery compared to centrifugation methods. Taken together, we envision that the developed DLD platform will enable fast and efficient isolation of MSCs from BMA for effective downstream cell therapy in clinical settings.
Subjects
Biomedical Engineering
General Chemistry
Biochemistry
Bioengineering
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Singapore-MIT Alliance in Research and Technology (SMART)
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Terms of Use
Creative Commons Attribution
https://creativecommons.org/licenses/by/3.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/154144
DOI of Published Version
https://doi.org/10.1039/d3lc00379e
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.